This grant from the National Institute on Aging aims to foster innovative research on marijuana, prescription opioid, and benzodiazepine use among adults aged 50 and above. The focus is on understanding the determinants of drug use in older populations, exploring neurobiological changes, associated behaviors, and public health impacts. Researchers are encouraged to investigate two groups of older adults: those with prior drug use history transitioning into later life, and those initiating drug use after the age of 50. The grant supports a wide range of research methodologies to advance knowledge on the causes and consequences of drug use in older adults, potentially informing risk assessment and clinical interventions in this demographic.
Opportunity ID: 298371
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PA-18-061 |
| Funding Opportunity Title: | Marijuana, Prescription Opioid, or Prescription Benzodiazepine Drug Use Among Older Adults (R01 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Nov 03, 2017 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | May 07, 2020 |
| Current Closing Date for Applications: | May 07, 2020 |
| Archive Date: | Jun 12, 2020 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Native American tribal governments (Federally recognized) For profit organizations other than small businesses State governments County governments Private institutions of higher education Small businesses Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Independent school districts Public and State controlled institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) Public housing authorities/Indian housing authorities Special district governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | Despite significant scientific advancements made in substance use disorder research over the last century, the causes and consequences of drug use in later life remain poorly understood. The intent of this funding opportunity announcement is to support innovative research that examines aspects of marijuana and prescription opioid and benzodiazepine use in adults aged 50 and older. This FOA encourages research that examines the determinants of these types of drug use and/or characterizes the resulting neurobiological alterations, associated behaviors, and public health consequences. This initiative will focus on two distinct populations of older adults: individuals with earlier onset of drug use who are now entering this stage of adult development or individuals who initiate drug use after the age of 50. Applications are encouraged to utilize broad methodologies ranging from basic science, clinical, and epidemiological approaches. The insights gleaned from this initiative are critical to our understanding of the determinants of drug use in later life, as well as its consequences in the aging brain and on behavior. This knowledge may have the potential to identify risk factors and to guide clinical practices in older populations. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PA-18-061.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-E | Use for due dates on or before May 24, 2020 | PKG00235713 | Jan 06, 2018 | May 24, 2020 | View | |
| FORMS-F | Use for due dates on or after May 25, 2020 | PKG00259270 | Jan 06, 2018 | May 07, 2020 | View |
Package 1
Mandatory forms
298371 RR_SF424_2_0-2.0.pdf
298371 PHS398_CoverPageSupplement_4_0-4.0.pdf
298371 RR_OtherProjectInfo_1_4-1.4.pdf
298371 PerformanceSite_2_0-2.0.pdf
298371 RR_KeyPersonExpanded_2_0-2.0.pdf
298371 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
298371 RR_Budget_1_4-1.4.pdf
298371 RR_SubawardBudget30_1_4-1.4.pdf
298371 PHS398_ModularBudget_1_2-1.2.pdf
298371 PHS_AssignmentRequestForm_2_0-2.0.pdf
Package 2
Mandatory forms
298371 RR_SF424_2_0-2.0.pdf
298371 PHS398_CoverPageSupplement_5_0-5.0.pdf
298371 RR_OtherProjectInfo_1_4-1.4.pdf
298371 PerformanceSite_2_0-2.0.pdf
298371 RR_KeyPersonExpanded_2_0-2.0.pdf
298371 PHS398_ResearchPlan_4_0-4.0.pdf
298371 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
298371 RR_Budget_1_4-1.4.pdf
298371 RR_SubawardBudget30_1_4-1.4.pdf
298371 PHS398_ModularBudget_1_2-1.2.pdf
298371 PHS_AssignmentRequestForm_3_0-3.0.pdf